R&D News | pharmaphorum

News

AbbVie extends Gedeon Richter alliance that gave it Vraylar

AbbVie's longstanding alliance with Hungarian drugmaker Gedeon Richter has already given it one blockbuster medicine – Vraylar for schizophrenia and bipolar disorder – and the two partners

News

Scenic Bio raises $31m for genetic modifier platform

18 months after signing its first partnering deal with Genentech, Scenic Biotech has raised $31 million in first-round financing that it will use to take its own genetic modifier-targeted m

News

Sanofi, Sobi eye filings for once-weekly haemophilia A thera...

Sanofi and Sobi's haemophilia partnership has been under competitive pressure from new therapies like Roche's antibody Hemlibra, so the two companies are hoping a new long-acting drug candi

News

Moderna targets 15 pathogens in 'global public health strate...

Moderna has unveiled plans to start clinical trials of mRNA-based vaccines for 15 infectious diseases that pose the biggest public health risks around the world – including HIV, malaria and

News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Novartis puts up $1.7bn for Voyager's gene therapy platform

Voyager Therapeutics has signed another big pharma partner for its TRACER adeno-associated virus (AAV) vector technology, designed to improve the safety of gene therapies, with Novartis tak

News

Mature Woman Experiencing Hot Flush From Menopause

Astellas' eyes filings for menopause drug fezolinetant after...

Astellas looks to be in pole position to bring a new non-hormonal therapy for symptoms of menopause to market, after its candidate fezolinetant cleared a phase 3 safety study.

AbbVie extends Gedeon Richter alliance that gave it Vraylar

Scenic Bio raises $31m for genetic modifier platform

Sanofi, Sobi eye filings for once-weekly haemophilia A thera...

Moderna targets 15 pathogens in 'global public health strate...

Novartis puts up $1.7bn for Voyager's gene therapy platform

Astellas' eyes filings for menopause drug fezolinetant after...

Danco fights back after US court curbs abortion pill access

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks